Sign in
Taking people in United StatesNo phase

Different sound settings for cochlear implant users who also wear a hearing aid

Tests a new sound pitch setting in adults with a cochlear implant and hearing aid.

Key facts

Who runs it
NYU Langone Health
Where
New York, United StatesSee the site
Trial code
Registry title
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
Status
Recruiting
People taking part
13 people, planned
Started
6 Oct 2024
Expected to end
6 Oct 2027
Type of study
Interventional
Treatments tested
  • Experimental frequency allocation table (FAT) - 438 Hz
  • Standard FAT - 188 Hz
Record updated
26 June 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults who use a cochlear implant in one ear and a hearing aid in the other ear. It tests a changed frequency setting of the implant.

Age
18 years or older
Sex
All sexes can join
Disease stage
Hearing loss in the hearing aid ear, with a pure tone average (.5, 1, and 2kHz) between 30 and 70 dB hearing level. Cochlear implant received at least 6 months ago, with at least 18 active electrodes.
Earlier treatment
Must use the cochlear implant regularly and keep programming appointments. Must use the standard frequency setting (FAT) for all programs before the trial. At least 25% of people should use the Cochlear EA32 electrode.

Main reasons for not taking part

  • Hearing worse than 70 dB hearing level in the hearing aid ear, or normal or mild hearing loss in that ear
  • Known problems with memory or thinking, or known abnormal ear structure
  • Not speaking English
  • Not using the device regularly
  • Non-standard frequency settings, or frequency transposition programming in the hearing aid

The registry criteria, word for word

Show all 17 criteriaShow less

Who can take part

  • Age 18 or older
  • Regular usage of a cochlear implant device with at least 18 active electrodes, and compliance with programming/appointments
  • Received a cochlear implant at least 6 months ago and use a hearing aid in the contralateral ear
  • Pure tone average (.5, 1, and 2kHz) between 30 and 70 dB (decibel) hearing level in the contralateral (hearing aid) ear
  • Standard FAT use for all programs prior to study participation
  • No known anatomical abnormalities in either ear
  • English speaking
  • No known cognitive impairments
  • At least 25% of subjects should use the Cochlear EA32 electrode

Who cannot take part

  • Under age 18
  • Non-English speaking. Participants that are Non-English speaking are excluded from this study due to the use of speech testing materials that are validated in the English language. Additionally, study team members are not equipped to appropriately score speech testing materials validated in other languages
  • Cognitively impaired
  • Non-consistent device usage
  • Greater than 70 dB hearing level pure tone average in the contralateral ear
  • Normal hearing or mild hearing loss in the contralateral ear
  • Non-standard FAT programs
  • Use of any frequency transposition programming in hearing aid

Where in United States

  • NYU Langone HealthNew York, United StatesContact: Mario Svirsky, PhDTaking people

About the trial

What the trial wants to find out

This study will examine experienced, bimodal cochlear implant (CI) patients who receive an alternative frequency allocation table (FAT) to determine how it improves sound quality, device satisfaction, and speech perception abilities with respect to the standard default FAT. The goal of this study is to investigate how improving place-pitch mismatch in bimodal CI users affects 1) sound quality, 2) satisfaction, and 3) speech perception.

The group in the trial

  • Experienced UsersTreatment being tested

    All subjects will be fit with a modified cochlear implant program ("experimental FAT") that changes which frequencies are presented to the cochlear implant. Subjects will complete a 1 month adaptation to the experimental FAT (438 Hz) and then a one month re-adaptation to the standard FAT (188 Hz). Speech perception tests and questionnaires will be collected before and after each FAT adaptation.

    Treatment: Experimental frequency allocation table (FAT) - 438 Hz and Standard FAT - 188 Hz

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
Plain-language title
Different sound settings for cochlear implant users who also wear a hearing aidGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
26 June 2026